Biogen Inc. buy BMO Capital Markets
Start price
26.07.23
/
50%
€243.00
Target price
26.07.24
€313.55
Performance (%)
-19.94%
End price
27.07.24
€194.55
Summary
This prediction ended on 27.07.24 with a price of €194.55. The prediction for Biogen Inc. disappointed with a performance of -19.94%. BMO_Capital_Markets has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 0.680% | 0.680% | -25.000% |
| iShares Core DAX® | -1.215% | 4.788% | 16.604% |
| iShares Nasdaq 100 | -1.911% | 1.109% | 19.364% |
| iShares Nikkei 225® | -3.171% | 5.626% | 10.519% |
| iShares S&P 500 | -1.029% | 1.792% | 20.514% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $357.00 to $347.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten